American Journal of Epidemiology Vol. 145, No. 5: 466-475
Copyright © 1997 by The Johns Hopkins University School of Hygiene and Public Health
other |
Smoking and Fatal Prostate Cancer in a Large Cohort of Adult Men
From the Department of Epidemiology and Surveillance Research, American Cancer Society Atlanta, GA
Reprint requests to Dr Carmen Rodnguez, Epidemiology and Surveillance Research, American Cancer Society, National Home Office, 1599 Clifton Rd., N E., Atlanta, GA 30329-4251.
The authors examined the relation between smoking and the risk of fatal prostate cancer in a large prospective mortality study of 450, 279 men who were cancer free at enrollment in 1982. During 9 years of follow-up, 1, 748 deaths occurred from prostate cancer. Cox proportional hazards modeling was used to adjust for other risk factors Current cigarette smoking was associated with fatal prostate cancer (rate ratio = 1.34, 95% confidence interval (Cl) 1.16–1.56). The rate ratio was greater at younger ages, decreasing from 1.83 (95% Cl 1.04–3.24) among men below the age of 60 years to 1 11 (95% Cl 079–1.58) among men aged 80 years and above (p for trend = 0.16). No trend in nsk was observed with the number of cigarettes per day or with the duration of smoking among current smokers at baseline, and no increased nsk was found among former smokers. Race did not significantly modify the association between cigarette smoking and fatal prostate cancer. These data, together with those of three other large prospective studies that find higher death rates from prostate cancer in current cigarette smokers, and inconsistent findings in incidence studies suggest that smoking may adversely affect survival in prostate cancer patients Am J Epidemiol 1997; 145: 466-75.
cohort studies; prostatic neoplasms; tobacco
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. T. Okino, L. C. Quattrochi, D. Pookot, M. Iwahashi, and R. Dahiya A Dioxin-Responsive Enhancer 3' of the Human CYP1A2 Gene Mol. Pharmacol., December 1, 2007; 72(6): 1457 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Conney Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture Cancer Res., November 1, 2003; 63(21): 7005 - 7031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Plaskon, D. F. Penson, T. L. Vaughan, and J. L. Stanford Cigarette Smoking and Risk of Prostate Cancer in Middle-Aged Men Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 604 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Charles, D. Loomis, C. M. Shy, B. Newman, R. Millikan, L. A. Nylander-French, and D. Couper Electromagnetic Fields, Polychlorinated Biphenyls, and Prostate Cancer Mortality in Electric Utility Workers Am. J. Epidemiol., April 15, 2003; 157(8): 683 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chapman and A. Dominello A strategy for increasing news media coverage of tobacco and health in Australia Health Promot. Int., June 1, 2001; 16(2): 137 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Y. Wang, M. Debiec-Rychter, H. A.J. Schut, P. Morse, R. F. Jones, C. Archer, C. M. King, and G. P. Haas N-Acetyltransferase expression and DNA binding of N-hydroxyheterocyclic amines in human prostate epithelium Carcinogenesis, August 1, 1999; 20(8): 1591 - 1596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Giovannucci, E. B. Rimm, A. Ascherio, G. A. Colditz, D. Spiegelman, M. J. Stampfer, and W. C. Willett Smoking and Risk of Total and Fatal Prostate Cancer in United States Health Professionals1 Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 277 - 282. [Abstract] [Full Text] [PDF]
|
|